UBS Call 164 CVX 16.01.2026/ CH1322952024 /
24/06/2024 9:47:03 | Diferencia-0.060 | Bid9:47:03 | Ask9:47:03 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
1.300EUR | -4.41% | 1.300 Volumen de oferta: 2,000 |
1.400 Tamaño/ Volumen/ Formato de Ask: 2,000 |
Chevron Corporation | 164.00 USD | 16/01/2026 | Call |
GlobeNewswire
9:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página